FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA to Convene Pharmacy Compounding Advisory Committee in July When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA considers adding a dozen peptides to its bulk drug compounding list RAPS